文献速递食管与纵隔外科

结肠代食管挽救性重建:单中心25年经验

Salvage esophageal reconstruction with colonic conduit: A single-center 25-year experience.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-09-25

该单中心回顾性研究分析了2000年至2024年间99例胸骨后结肠代食管患者的围术期结局、部分患者报告症状及生存情况。

要点

  • 微血管超级增压可显著降低结肠代食管颈部吻合口漏风险
  • 长期功能结局与胃代食管患者相似,挑战传统认知
  • 合并食管癌患者10年总生存率低于无食管癌患者

核心结论

  • 结肠代食管短期并发症可通过微血管超级增压和多学科标准化管理减轻,长期功能结局与胃代食管相似。

研究设计与样本

  • 单中心回顾性研究,纳入2000年1月至2024年6月共99例胸骨后结肠代食管患者。

主要发现

  • 18例CEQ问卷中,每周餐后腹泻和腹胀最常见,分别占56%和50%。
  • 结肠代食管各症状域CEQ T评分中位数为42-56,胃代食管为40-47。

关键数值与推荐

  • 83例(84%)使用基于肠系膜下动脉的横结肠段,16例(16%)接受超级增压。

临床怎么用

  • 在胃代食管不可用时,可考虑结肠代食管并常规应用微血管超级增压以降低吻合口漏风险。

局限性

  • 单中心回顾性设计,CEQ评估仅纳入18例患者,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Colonic interposition restores alimentary continuity after esophagectomy when a gastric conduit is unavailable, but its use has been limited by concerns about morbidity and functional outcomes. Hence, we aimed to assess our 25-year institutional experience, including perioperative outcomes, a subset with patient-reported outcomes, and a contemporary cohort treated with middle-colic microvascular "supercharging" to augment perfusion. METHODS: From January 2000 to June 2024, 99 patients underwent substernal colonic interposition. End points included perioperative outcomes, postoperative symptoms, assessed by Cleveland Clinic Esophageal Questionnaire (CEQ), and overall survival estimated by Kaplan-Meier method. RESULTS: Median age was 61 [47, 73] years. Forty-eight (48%) patients had esophageal cancer. An inferior mesenteric artery-based transverse colon segment was used in 83 (84%). Sixteen (16%) underwent supercharge. Thirty-day mortality was 5%. One patient with supercharge (6.3%; 68% confidence interval, 2.3%-16%), and 36 without (43%; confidence interval, 38%-49%), developed a cervical anastomotic leak (P = .004). Among 18 patients with CEQ scores, most symptoms were experienced never or rarely; weekly postprandial diarrhea and bloating were the most common symptoms, reported by 10 (56%) and 9 (50%) patients, respectively. Median CEQ T scores for each symptom domain ranged from 42 to 56 after colon interposition versus 40 to 47 after gastric conduit. Overall survival with and without esophageal cancer was 25% to 66% at 10 years (P < .0001). CONCLUSIONS: Colonic interposition historically carried substantial short-term morbidity attributable to sequelae of frequent anastomotic leaks. Presently, this can be mitigated with microvascular supercharge and a standardized multidisciplinary approach, warranting routine use. Contradicting conventional wisdom, long-term functional outcomes are similar to patients with a gastric conduit.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Barron JO, Ramji S, Jain N, et al. Salvage esophageal reconstruction with colonic conduit: A single-center 25-year experience. J Thorac Cardiovasc Surg. 2025. PMID: 41015251. doi:10.1016/j.jtcvs.2025.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。